Literature DB >> 25682850

A cohort study of diabetic patients and diabetic foot ulceration patients in China.

Yufeng Jiang1,2,3, Xuemei Wang4, Lei Xia1, Xiaobing Fu1,2, Zhangrong Xu3, Xingwu Ran5, Li Yan6, Qiu Li7, Zhaohui Mo8, Zhaoli Yan9, Qiuhe Ji10, Qiang Li11.   

Abstract

To determine the annual incidence and clinically relevant risk factors for foot ulceration in a large cohort study of diabetic foot ulcer (DFU) patients and diabetes mellitus (DM) patients in China. To investigate a cohort of 1,333 patients comprising 452 DFU patients and 881 DM patients, who underwent foot screening, physical examination, and laboratory tests in eight hospitals. The patients were assessed at baseline in terms of their demographic information, medical and social history, peripheral neuropathy disease (PND) screening, periphery artery disease (PAD) screening, assessment of nutritional status, and diabetic control. One year later, the patients were followed up to determine the incidence of new foot ulcers, amputation, and mortality. By univariate analysis, statistically significant differences were found in age, location, gender, living alone (yes/no), occupation, smoking, hypertension, PND, PAD, nephropathy, retinopathy, cataracts, duration of diabetes, Glycosylated hemoglobin A (HbA1c), fasting plasma glucose level, postprandial blood glucose level, insulin level, blood urea nitrogen, creatinine, cholesterol, triglyeride, high density lipoprotein (HDL), serum albumin, white blood cell, and body mass index. A binary logistic regression model was used to examine which of these risk factors were independent risk factors for foot ulceration. A total of 687 (51.5%) of the 1,333 patients were followed up for an average of 12 months; there were 458 DM patients and 229 DFU patients. A total of 46 patients died during the follow-up period; 13 were DM patients, and 33 were DFU patients. Of the 641 patients, 445 (69.4%) patients were DM patients, and 196 (30.6%) were DFU patients. At follow-up, 36/445 DM patients (8.1%), and 62/196 DFU patients (31.6%), developed new ulcers; 10/196 DFU patients underwent an amputation. The annual incidence of ulceration for DM patients and amputation for DFU patients were 8.1 and 5.1%, respectively. The annual mortality of the DM patients and DMF patients were 2.8 and 14.4%, respectively. A binary logistic regression model was used to examine which risk factors were independent risk factors for foot ulceration during the follow-up period, and the final results showed that nephropathy (odds ratio 2.32), insulin level (odds ratio 3.136, 2.629), and decreased HDL (odds ratio 0.427) were associated with increased risks for foot ulceration. Complications of diabetes affecting the feet represent a serious problem in China. The incidence of foot ulcers and amputation are much higher than that of Western countries. More intensive surveillance and aggressive care following a diagnosis of DFU and earlier referral to specialty care might improve the patient outcome.
© 2015 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25682850     DOI: 10.1111/wrr.12263

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  27 in total

1.  [Treatment of severe diabetic foot ulcer using tibia transverse transport combined with nose ring drain].

Authors:  Jie Yu; Qikai Hua; Xiaocong Kuang; Jie Liu; Guangwei Liu; Shanlang Li; Xinyu Nie; Hongjie Su; Yi Ding; Zhaowei Zhong; Jiangtao Yang; Liexun He; Yan Chen
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-08-15

2.  WDR74 facilitates TGF-β/Smad pathway activation to promote M2 macrophage polarization and diabetic foot ulcer wound healing in mice.

Authors:  Kang Geng; Xiumei Ma; Zongzhe Jiang; Junling Gu; Wei Huang; Weiming Wang; Yong Xu; Youhua Xu
Journal:  Cell Biol Toxicol       Date:  2022-08-19       Impact factor: 6.819

3.  [Development of a Diabetic Foot Ulceration Prediction Model and Nomogram].

Authors:  Eun Joo Lee; Ihn Sook Jeong; Seung Hun Woo; Hyuk Jae Jung; Eun Jin Han; Chang Wan Kang; Sookyung Hyun
Journal:  J Korean Acad Nurs       Date:  2021-06       Impact factor: 0.984

4.  [Treatment of diabetic foot with vaccum sealing drainage combined with transverse tibial bone transport].

Authors:  Shunan Dong; Dong Huang; Lilin Zhu; Xiaoyan Liu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-07-15

5.  Nomogram Model for Predicting the Risk of Multidrug-Resistant Bacteria Infection in Diabetic Foot Patients.

Authors:  Yi-Ni Ma; Li-Xiang Zhang; Yuan-Yuan Hu; Tian-Lu Shi
Journal:  Infect Drug Resist       Date:  2021-02-18       Impact factor: 4.003

6.  Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Facilitate Diabetic Wound Healing Through MiR-17-5p-mediated Enhancement of Angiogenesis.

Authors:  Qian Wei; Yaxi Wang; Kui Ma; Qiankun Li; Bingmin Li; Wenzhi Hu; Xiaobing Fu; Cuiping Zhang
Journal:  Stem Cell Rev Rep       Date:  2021-05-04       Impact factor: 5.739

7.  Risk Factors for Major Amputation in Diabetic Foot Ulcer Patients.

Authors:  Qingwei Lu; Jun Wang; Xiaolu Wei; Gang Wang; Yang Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-04       Impact factor: 3.168

8.  Exploring the barriers of patients with diabetic foot complications in China: a qualitative interview study.

Authors:  Xiaoli Liu; Hongling Chu; Jinghui Zhao; Rui Qiao; Yuqiang Liu; Nan Li; Lin Zeng; Xiaoxiao Wang; Liyuan Tao; Hua Zhang; Yanyan Shi; Lin Zhuo; Long Zhang; Yiming Zhao
Journal:  Ann Transl Med       Date:  2021-05

9.  Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

Authors:  Ju-Yi Li; Xiao-Yan Yang; Xiu-Fang Wang; Xiong Jia; Zhong-Jing Wang; Ai-Ping Deng; Xiang-Li Bai; Lin Zhu; Bing-Hui Li; Zi-Bo Feng; Ye Li; Ling Wang; Si Jin
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

10.  Development and validation of a brief diabetic foot ulceration risk checklist among diabetic patients: a multicenter longitudinal study in China.

Authors:  Qiuhong Zhou; Min Peng; Lihuan Zhou; Jiaojiao Bai; Ao Tong; Min Liu; In I Ng; Yuxia Cheng; Yunmin Cai; Yujin Yang; Yilian Chen; Suwen Gao; Zhong Li; Xiaoai Fu; Minxue Shen; Jianglin Zhang; Xiang Chen
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.